Microsoft Word - MD&A 2017 EN.doc EFORL IR010/2018 March 20, 2018 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2017 To President The Stock Exchange of Thailand 1. Overview

[COMPANY NAME] EFORL IR010/2018 March 20, 2018 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2017 To President The Stock Exchange of Thailand 1. Overview financial

1 EFORL 031/2017 August 15, 2017 Subject: Notification the waiver of subscription right to capital increase of WCI Holding Co., Ltd. To: President The Stock Exchange of Thailand Ref: Letter no. EFORL

Stock Exchange of Thailand 1. Overview financial performance of E for L Aim Public Company Limited (“EFORL” or “the Company”) and its subsidiaries (collectively as “the Companies”) for Q3/2017 Financial

อี ฟอร์ แอล เอม จ ากดั (มหาชน) (“EFORL”) ได้ลงนามในบนัทึกข้อตกลง “MOU”ลงทนุในธุรกิจบริการทาง การแพทย์เพื่อสขุภาพ ความงาม ภายใต้เคร่ืองหมายการค้า “วุฒิศกัดิ์ คลินิก” แล้ว โดย HHC จะซือ้ทรัพย์สินจ านวน

Healthcare Center Co., Ltd. “HHC” - a subsidiary of FVC, and Wuttisak Clinic Inter Group Co., Ltd. “WCIG”- an indirect subsidiary of E FOR L Aim Public Co., Ltd. “EFORL” , of which details appeared on the

. “EFORL” , of which details appeared on the above-mentioned letters; and any further progress shall be informed to SET appropriately. From the aforesaid signings, HHC shall be entitled to operate “Wuttisak

AIM 1 Ref.: EFORL IR 043/2018 November 14, 2018 Subject: Management Discussion and Analysis for the third quarter of 2018 (Q3/2018) and for nine month periods ended September 30, 2018 To President

performance of E for L Aim Public Company Limited (“EFORL” or “the Company”) and its subsidiaries (collectively as “the Companies”) for Q1/2018 Financial performances Comparison is as follows: THB’000

of Thailand 1. Overview financial performance of E for L Aim Public Company Limited (“EFORL” or “the Company”) and its subsidiaries (collectively as “the Companies”) for Q2/2018 Financial performances